Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children.
Ontology highlight
ABSTRACT: Fluoxetine therapy has been approved for children with major depressive disorder and obsessive compulsive disorder for over 14 years and has expanded to other childhood behavior disorders. As use increases, more detail on fluoxetine effects during juvenile brain development can help maintain safe and effective use of this therapy. Here, a narrative review is provided of previously published findings from a large nonhuman primate project. Fluoxetine was administered to juvenile male rhesus monkeys for an extended period (2 years) prior to puberty. Compared to controls, treated monkeys showed sleep disruption, facilitated social interaction, greater impulsivity, and impaired sustained attention during treatment. No effects on growth were seen. Metabolomics assays characterized a distinctive
SUBMITTER: Golub MS
PROVIDER: S-EPMC5809484 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA